B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

SI

MOLECULAR TARGET

sucrase-isomaltase

UniProt: P14410NCBI Gene: 64766 compounds

SI (sucrase-isomaltase) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting SI

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1duvoglustat4.3476
2miglitol3.6136
3miglustat3.5032
41-Deoxynojirimycin2.8316
5migalastat2.6413
6Quercetin0.691

About SI as a Drug Target

SI (sucrase-isomaltase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented SI interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

SI inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.